SANOFI VACCINES US INC. - DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
Key Details
Description
DEVELOPMENT AND DOMESTIC MANUFACTURE OF ADJUVANTED, PANDEMIC INFLUENZA VACCINES
Context & Analysis
On Dec 3, 2025, Department of Health and Human Services obligated $612,225,077.34 to SANOFI VACCINES US INC. for development and domestic manufacture of adjuvanted, pandemic influenza vaccines. The award is classified under NAICS 325414 — BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING and issued as a cost plus fixed fee contract. Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325414 — related awards are listed below.
Market context
- Competition
- Not competed. 48% of 44 awards in this market (Department of Health and Human Services awards in NAICS 325414 over the last 3 years) were competed; median 2 offers.
- Award size
- At $612.2M, this award is larger than 19 in 20 of the 39 priced Department of Health and Human Services awards in NAICS 325414 over the last 3 years (median $270K).
- Incumbent at this agency
- SANOFI VACCINES US INC. has 20 other awards from Department of Health and Human Services, totalling $2.9B, 2025–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 325414 over the last 3 years.
- ADVANCED TECHNOLOGY INTERNATIONAL — 10 awards, $917.0M
- SEQIRUS INC — 3 awards, $30.0M
- MILTENYI BIOTEC, INC. — 2 awards, $5.1M
- HOLOGIC SALES AND SERVICE, LLC — 2 awards, $1.6M
- VBI VACCINES (DELAWARE) INC. — 1 award, $152K
Computed from USAspending award data on Oct 25, 2026.
Contractor Information
Similar Awards
OTHER TRANSACTION: PRODUCTION OF DRUG SUBSTANCES AND DRUG PRODUCTS AT COMMERCIAL SCALE UNDER BIOMAP-CONSORTIUM
ADVANCED TECHNOLOGY INTERNATIONAL
$304.0M
EXPANSION OF PRODUCTION CAPACITY OF MAN-MADE FABRIC FOR MANUFACTURING DISPOSABLE MEDICAL GOWNS
ADVANCED TECHNOLOGY INTERNATIONAL
$248.5M
OTHER TRANSACTION: PROCUREMENT AND SUSTAINMENT OF N95 MASK MANUFACTURING CAPACITY UNDER THE BIOMAP-CONSORTIUM.
ADVANCED TECHNOLOGY INTERNATIONAL
$141.3M
EXPANSION OF DOMESTIC MANUFACTURING CAPACITY FOR NITRILE GLOVES
ADVANCED TECHNOLOGY INTERNATIONAL
$61.0M
MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE
SANOFI VACCINES US INC.
$53.2M
Stay Updated
Get notified about new opportunities matching your interests.